market research reports
0 view | +0 today
Follow
 
Scooped by praveen12321
onto market research reports
Scoop.it!

Global Foodborne Diseases Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Foodborne diseases cover a broad spectrum of illnesses that are affecting the people worldwide. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals. The contamination occurs from any way either soil, water or air. The most common foodborne infections are caused by three bacteria campylobacter, salmonella, and E.coli and by a group of viruses called calicivirus. Clinical symptoms of foodborne diseases seen in gastro intestinal tract. Symptoms include vomiting, diarrhea, and abdominal pain. In some cases, such diseases can also have neurological, gynecological, immunological and other symptoms. Common foodborne diseases include botulism, salmonellosis, traveler’s diarrhoea, gastroenteritis, tapeworm infection and hepatitis A, among others.

 

Global foodborne diseases treatment market is driven by the increasing incidence of foodborne diseases worldwide. In addition, increase in R&D investment, growing awareness about foodborne disease symptoms due to initiatives of government and non-government organizations such as WHO, and lack of hygiene conditions are boosting the foodborne diseases treatment market worldwide. However, the high cost of R&D investment for development of anti microbial and stringent, time-consuming regulatory procedures are expected to hinder the foodborne diseases market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Foodborne diseases treatment market has been segmented based on disease, drug class, and distribution channel

 

Based on drug class, foodborne diseases treatment market is segmented into

  • Antibiotics
  • Anti Diarrhea
  • Fluids and Electrolyte Replenishers
  • Vaccines
  • Others

 

Based on disease, foodborne diseases treatment is segmented into

  • Botulism
  • Traveler’s Diarrhea
  • Gastroenteritis
  • Toxoplasmosis
  • Others

 

Based on route of administration, foodborne diseases treatment market is segmented into

  • Parenteral
  • Oral
  • Others

 

Based on distribution channel, foodborne diseases treatment market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Foodborne diseases treatment market is expected to grow at significant CAGR during the forecast period. According to the findings of WHO – “Estimates of the global burden of foodborne diseases” 2015, almost 1 in every10 people fall ill yearly due to contaminated food consumption and 420,000 deaths occour as a result. Market players are adopting drug developments and collaborations as key market strategies.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically Foodborne Diseases Treatment Market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America foodborne diseases treatment market is expected to grow at notable rates due to increase in the prevalence of foodborne diseases such as botulism and toxoplasmosis, and increase in R&D investment by companies on antibiotics and vaccines. Asia Pacific and Africa regions are projecting lucrative opportunity for foodborne diseases treatment market owing to increase in the incidence of foodborne diseases in these regions. According to WHO estimates 2015, Africa and South East Asia regions have the highest incidence and death rates, including children under the age of 5 years. Europe is expected to show significant growth rate owing to increase in R&D investment and healthcare spending.

 

Some of the market players in foodborne diseases treatment market are Bayer AG (Germany), Johnson & Johnson Services Inc., (U.S.), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), XOMA Corporation (U.S.), AlphaVax, Inc. (U.S.), Molecular Targeting Technologies, Inc. (U.S.), and Morphotek Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/

more...
No comment yet.
Your new post is loading...
Your new post is loading...
Scooped by praveen12321
Scoop.it!

Global Sterile Injectables Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Sterile Injectables Market: By Molecule Type (Large Molecules, Small Molecules), Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Vaccines, Immunoglobulins, Peptide Antibiotics, and Others), Disease Indication (Cancer, Diabetes, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Route of Administration (Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 Sterile Injectables Market Report Description:

 Sterile Injectables market report gives a comprehensive outlook on sterile injectable across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on the sterile injectable market gives historical, current, and future market sizes (US$ Mn) of drug molecules, drug types, disease application, route of administration, end users, and geographic regions. This report studies sterile injectable market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the sterile injectable market report includes drug pipeline analysis, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed sterile injectable market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the sterile injectable market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of sterile injectables.

 

 

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Sterile Injectables Market:

 

The sterile injectable market estimated to be valued US$ 361 Bn in 2016 and poised to grow at CAGR 7.3%. The market for sterile injectable projected to reach US$ 552 Bn by 2023.

 

Do the burgeoning product pipelines and drug patent expiries have a positive impact on the market?

 

The rising shift of pharmaceutical and biotechnology firms towards the development of medications for chronic diseases such as cancer, diabetes, and cardiovascular and among others have created ample growth opportunities for players in the market. Moreover, biologic have become a larger part of product pipelines of several drug developers, which could affect market growth positively over the forecast period. For instance, there are around 2,500 injectable products are in the developmental stage. Moreover, rising product patent expiries of several blockbusters in recent times expected to propel market growth over the forecast period. For instance, in 2015, Teva Pharmaceutical Industries Ltd. lost the patent for its top-selling multiple sclerosis drug Copaxone.

 

How operational and installation cost effects the sterile injectable market?

 

Several industry experts noted that the cost of establishing sterile injectable plants is significantly higher viz-a-viz non-sterile manufacturing plants owing to stringent aseptic requirements and complex manufacturing process; this has led to the consolidation of the industry by backward and forward integration. Moreover, competition from low-cost manufacturers, value chain integration coupled with high entry barrier for new players in the sterile injectable market expect impact market growth negatively over the forecast period.

 

North America accounts for larger market revenue share in global sterile injectable market

 

North America leads the global sterile injectable market in terms of revenue in 2016. Regions such as Asia Pacific and Europe presented better growth opportunities for the market players owing to conducive business policies and increased local production generic injectable. For instance, in 2013, Mylan Inc. completed the acquisition of the Agila injectables businesses from Strides Arcolab Limited.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/#ulp-c654SbFYO64MsOhu

 

 

Competition Assessment

 

Key players profiled in the global sterile injectable market include:

  • AbbVie Inc. (U.S)
  • Amgen Inc. (U.S)
  • AstraZeneca plc (U.K)
  • Baxter International Inc. (U.S)
  • Eli Lilly and Company (U.S)
  • GILEAD SCIENCES, INC. (U.S)
  • GlaxoSmithKline plc. (U.K)
  • Johnson & Johnson Services, Inc. (U.S)
  • Merck & Co., Inc. (U.S)
  • Novo Nordisk A/S (Denmark)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S)
  • Hoffmann-La Roche AG (Switzerland)
  • Sanofi (France)

Market players are focusing on mergers and acquisitions to improve their market position in sterile injectable market. For instance, in 2016, Baxter International Inc. acquired Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited, for total consideration of approximately $625mn. In 2015 Pfizer Inc. acquired Hospira, Inc., world’s leading provider of injectable and infusion technologies.

Key Findings of the Report:

 

  • Sterile injectable market expanding at 7.3% CAGR over 2017 to 2023 to reach market value of US$ 552 Bn by 2023
  • Based on molecule type large molecules accounted for larger market share in 2016
  • Oncology segment expected to be most lucrative market in global sterile injectable market
  • Hospital pharmacies are prime channel for sterile drug distribution across the globe
  • Players focusing on expanding geographic presence to garner market opportunities in developing economies

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/#ulp-14mlyhjMGhVjZqa3

 


Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

 

By Molecule Type

  • Large Molecules
  • Small Molecules

Drug Type

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Vaccines
  • Immunoglobulins
  • Peptide Antibiotics
  • Others

Disease Indication

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Others

Route of Administration

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others

 

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Geography

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • K.
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Venezuela
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • Gulf Cooperation Council (GCC) Countries
    • Israel
    • South Africa
    • Rest of MEA

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Heart Valves Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Heart valves are the medical devices which are used in the replacement of defective heart valve. Heart valves are majorly 2 types, they are biological or tissue and mechanical heart valves. Biological heart valves are made up of various tissues such as porcine, bovine and human tissues. Heart valves made from human tissues are known as homografts or allografts. The major advantage of tissue valves over mechanical valve is mechanical heart valves can cause bleeding and increase the chances of reoperations in geriatric people. Since the use of tissue heart valves in people of this age group lowers the risks of bleeding. Physicians are increasingly opting for this method as it able to reduce the use of oral anticoagulation drugs for the management of bleeding complications.

 

The heart valves market is growing at a significant CAGR due to increase in geriatric population, and increase in the prevalence of heart valve diseases. The increase in demand for stentless tissue valves, implementation of MI procedures expected to fuel the growth of Heart valves market. Rising in preference for tissue heart valve replacement surgeries among the geriatric population is also boosting the growth of Heart valves market over the forecast period. However, lack of skilled professional, the risk of potential complications with tissue valves, and use of alternate products might hamper the growth of Heart valves market over the forecast period. Similarly, the stringent regulatory framework for product approvals expected to dampen the growth of Heart valves market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-heart-valves-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The heart valves market is segmented on the basis of product type, valve type, harvesting type, and end users

 

Based on product type, heart valves market has been segmented into the following:

  • Stented tissue heart valves
  • Stentless tissue heart valves

 

Based on valve type, heart valves market has been segmented into the following:

  • Aortic tissue valves
  • Mitral tissue valves

 

Based on the harvesting, heart valves market has been segmented into the following:

  • Autograft
  • Homograft
  • Heterograft

 

Based on end-user, heart valves market has been segmented into the following:

  • Hospitals
  • Clinics
  • Ambulatory surgical centers

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-heart-valves-market/#ulp-c654SbFYO64MsOhu

 

 

Global heart valves market is increasing due to rise in the prevalence of cardiac disorders. The most commonly adopted strategies by industry players include new product launches with technological innovations, acquisitions & mergers, agreements, and collaborations to capture significant Heart valves market share. They acquire other companies to enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. Acquisition of other companies allows vendors access to the product portfolio of the acquired company. For instance, in December 2012, Edwards Lifesciences Corporation and Cook Biotech Incorporated, have collaborated into a technology licensing and supply agreements for the development of tissue-engineered heart valves and related cardiovascular implants.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-heart-valves-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, heart valves market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to hold a dominant share in Heart valves market owing to increase in the prevalence of heart valve diseases, increasing research and development, favourable medical reimbursement policies increase the growth of Heart valves market in North America. Europe region holds second largest share attributed to increases in the prevalence of heart valve diseases because of changing lifestyle. Increasing government funding for R&D, technological advancements are expected to boost the growth of Heart valves market. Asia-pacific region is expected to hold the large share in forecast period due to increase in awareness regarding tissue valves, increasing geriatric population and rising opportunities in medical tourism.

 

Some of the players in the heart valves market are Edwards Lifesciences Corporation (U.S.), LivaNova PLC (U.K.), Medtronic (U.S.), St. Jude Medical (Abbott Laboratories) (U.S.), Braile Biomédica (Brazil), CryoLife, Inc. (U.S.), and Laboratory Corporation of America (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-heart-valves-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Foodborne Diseases Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Foodborne diseases cover a broad spectrum of illnesses that are affecting the people worldwide. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals. The contamination occurs from any way either soil, water or air. The most common foodborne infections are caused by three bacteria campylobacter, salmonella, and E.coli and by a group of viruses called calicivirus. Clinical symptoms of foodborne diseases seen in gastro intestinal tract. Symptoms include vomiting, diarrhea, and abdominal pain. In some cases, such diseases can also have neurological, gynecological, immunological and other symptoms. Common foodborne diseases include botulism, salmonellosis, traveler’s diarrhoea, gastroenteritis, tapeworm infection and hepatitis A, among others.

 

Global foodborne diseases treatment market is driven by the increasing incidence of foodborne diseases worldwide. In addition, increase in R&D investment, growing awareness about foodborne disease symptoms due to initiatives of government and non-government organizations such as WHO, and lack of hygiene conditions are boosting the foodborne diseases treatment market worldwide. However, the high cost of R&D investment for development of anti microbial and stringent, time-consuming regulatory procedures are expected to hinder the foodborne diseases market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Foodborne diseases treatment market has been segmented based on disease, drug class, and distribution channel

 

Based on drug class, foodborne diseases treatment market is segmented into

  • Antibiotics
  • Anti Diarrhea
  • Fluids and Electrolyte Replenishers
  • Vaccines
  • Others

 

Based on disease, foodborne diseases treatment is segmented into

  • Botulism
  • Traveler’s Diarrhea
  • Gastroenteritis
  • Toxoplasmosis
  • Others

 

Based on route of administration, foodborne diseases treatment market is segmented into

  • Parenteral
  • Oral
  • Others

 

Based on distribution channel, foodborne diseases treatment market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Foodborne diseases treatment market is expected to grow at significant CAGR during the forecast period. According to the findings of WHO – “Estimates of the global burden of foodborne diseases” 2015, almost 1 in every10 people fall ill yearly due to contaminated food consumption and 420,000 deaths occour as a result. Market players are adopting drug developments and collaborations as key market strategies.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically Foodborne Diseases Treatment Market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America foodborne diseases treatment market is expected to grow at notable rates due to increase in the prevalence of foodborne diseases such as botulism and toxoplasmosis, and increase in R&D investment by companies on antibiotics and vaccines. Asia Pacific and Africa regions are projecting lucrative opportunity for foodborne diseases treatment market owing to increase in the incidence of foodborne diseases in these regions. According to WHO estimates 2015, Africa and South East Asia regions have the highest incidence and death rates, including children under the age of 5 years. Europe is expected to show significant growth rate owing to increase in R&D investment and healthcare spending.

 

Some of the market players in foodborne diseases treatment market are Bayer AG (Germany), Johnson & Johnson Services Inc., (U.S.), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K), Novartis AG (Switzerland), XOMA Corporation (U.S.), AlphaVax, Inc. (U.S.), Molecular Targeting Technologies, Inc. (U.S.), and Morphotek Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Corneal Implants Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Corneal Implants are also called as corneal inlays that are the optical devices inserted into cornea to improve vision. The main purpose of optical devices is to improve the near vision and reducing need for reading spectacles in adults with presbyopia. Corneal implants are one of the options for the rectification of declined near vision in people with presbyopia who desires to have spectacle-independent superior vision for all distances. Corneal implantable devices have also been used for correction of hyperopia, myopia, and astigmatism.

 

As per to the Eye Bank Association of America (EBAA), the number of endothelial keratoplasty cases in the U.S. was over 23,000 in 2012 and corneal surgery was the most adopted choice to avoid blindness and restore the damaged eye. According to EBAA, presbyopia affects nearly over 80-90% population over the age of 40 years worldwide. Global corneal implants market continues to witness positive growth owing to increased cataract development over the age of 65, increasing life expectancy, and rising geriatric population would expect to fuel demand ocular implants over a period of forecast. An increase in the number of keratoplasty cases and corneal surgeries will boost market growth over the forecast period. The market for ocular implants driven by technological advances in implants like multifocal intraocular lens technology and rising awareness about aesthetics among young patient population expected to fuel the market for ocular implants over a period of forecast. However, potential side effects or damage associated with the use of ocular implants to the eye, the dearth of a skilled workforce to perform the implantation procedures may hamper the growth of the ocular implants market over a period of forecast.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-corneal-implants-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The market for corneal implantable devices has been segmented on the basis of the type of implant, end-user, and geography.

 

Based on type of implant, corneal implantable devices has been segmented as

  • Refractive Corneal Implantable Device
  • Corneal Reshaping Implantable Device
  • Small Aperture Corneal Implantable Device

 

Based on end-user, corneal implantable devices has been segmented as

  • Hospitals
  • Ophthalmic Clinics
  • Retail Ophthalmic Stores
  • Online Retail.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-corneal-implants-market/#ulp-c654SbFYO64MsOhu

 

 

Global corneal implants market is highly fragmented with several local and international players offering different implantable products in the marketplace. Players or service providers in the ocular implants market are coming up with a customized solution that addresses the patient requirements. Players in ocular implants market are developing newer designs which are influenced by viscoelastic technology and others to gain larger market revenue share in the ocular implants market. Moreover, end users (Service providers) in the market continuously working towards educating the patients regarding implantation surgeries and post-surgery precautions. The ophthalmic clinic’s segment is anticipated to witness high revenue share owing to a larger proportion of inpatient corneal implant procedures in these clinics and thus a greater demand for corneal implantable devices from this segment. Corneal implants market is estimated to witness considerable growth prospects from 2017 to 2023 corneal implants have been developed as a treatment option for corneal ectasia.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-corneal-implants-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, corneal implants market is segmented as five regions, North America, Latin America, Asia Pacific, Europe and The Middle East & Africa. North America and Europe are expected to be as the dominating markets in corneal implants market, owing to awareness about corneal implants and rise in adoption of the patient for the technique. U.S.A corneal implants market is boosting the regional industry owing to the high prevalence of the ophthalmic and ocular conditions and early diagnosis of the eye disorders. The availability of advanced products, such as Raindrop Near Vision Inlay, used to correct near vision in patients with presbyopia will bolster the corneal implants market in the country.

 

As per the EU National Statistics, it is estimated as that there were over 209 Mn Europeans suffering from presbyopia and it is projected as that nearly half of the Europeans population will suffer from presbyopia by 2030 which may propel the Corneal Implants market during the forecast period. Spain market for corneal implants will expect lucrative growth over the forecast period. The growth is attributed due to consumers are willing to spend for eye care in the country.

 

Asia-Pacific represents a vast population with an unmet need in the domain of ocular aging treatment. In Japan, it has been observed that youth in their 20’s and 30’s are witnessing presbyopia-like symptoms due to overuse of devices and technology such as smartphones. These demographic and lifestyle changes coupled with the highest number of aging population is anticipated to bolster the corneal implants market in Asia-Pacific during the forecast period.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-corneal-implants-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Stem Cell Therapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Stem cell therapy market: Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every tissue and organ in the body.  Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others.

 Global Market Outline: Stem Cell Therapy Market

 Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis techniques and increase in public, private investments in stem cell research are acting as growth drivers for stem cell therapy market. In addition, identification of new stem cell lines and development of infrastructure for stem cell banking & processing are propelling the growth of the global stem cell therapy market. However, ethical issues involved in stem cells research such as destruction of human embryos, religious beliefs are considered as road blocks for adaptation of stem cell therapy by patients. However, stringent regulations to conduct trials on humans, high-cost of research and storage of stem cells are some restraining factors for stem cell therapy market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Stem cell therapy market has been segmented on the basis of treatment mode, cell types, application, technology, and end-user

 

Based on treatment, stem cell therapy market is segmented into

  • Allogeneic
  • Autologous

 

Based on cell type, stem cell therapy market is segmented into

  • Adult Stem cells
  • Induced Pluripotent Stem cells
  • Human Embryonic Stem Cells
  • Others

 

Based on technology, stem cell therapy market is segmented into

  • Cell Production
  • Cell Acquisition
  • Cryopreservation

 

Based on end-user, stem cell therapy market segmented into

  • Hospitals
  • Ambulatory Centers
  • Research Centers

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/#ulp-c654SbFYO64MsOhu

 

 

Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI’s induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically stem cell therapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among the regions, North America dominates global stem cell therapy market due to factors such as increasing prevalence of chronic diseases, growing awareness, and rising investment in research and development activities. In Asia Pacific region, due to the favourable government policies, development healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore,  and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline.

 

Some of the players in stem cell therapy market are Cytori Therapeutics Inc. (U.S.), Fibrocell Science (U.S.), Cellartis AB (Cellectis) (France), BioTime, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), STEMCELL Technologies Inc. (Canada), Fujifilm Holdings Corporation (Japan), Vericel Corporation (Aastrom Bioscience) (U.S.), Brainstorm cell therapeutics (U.S.), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), Celgene Corporation (U.S.), and Osiris Therapeutics, Inc. (U.S.) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/

 

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Healthcare BPO Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Business Process Outsourcing (BPO) is a process where healthcare providers select the most appropriate third party vendors for some of the specific business procedures. It allows the hospitals and medical professionals to spend their energy and valuable time on patient care rather than doing some paper work in the office.  Healthcare BPO is a solution for clients to adopt intelligent approaches that will support the organization to reduce the cost pressures and increase in the overall productivity. Healthcare BPO market provides various solutions, such as front-end services, customer account setup, billing & account receivables, provider network services, enrollment services, claims services, Medicare services, membership services, and pharmacy benefits management.

 

Healthcare BPO market is primarily driven by a few key factors such as lack of in-house trained professionals for specific processes, cost-effective availability of workforce, and lack of industry knowledge. The pressure to decrease delivery costs healthcare sector, rise in number of insurance seeking patients, pharmaceutical companies facing patent expiries, consolidation of the healthcare systems and implementation of the ICD-10 codes and lower cost of manufacturing in developing countries are the major drivers for the healthcare BPO market. However, with the ongoing trends in the healthcare BPO, customers face challenges in data security & reliability, increasing regulatory compliance, and handling huge amount of healthcare data, fear of losing the control over many outsourced process, probability of decreased quality of services or products, and insecurity for the data are the factors anticipated to hamper the healthcare BPO market growth.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Healthcare BPO market is segmented on the basis of provider services, payer services, pharmaceutical services, end users, and geographical regions.

 

Healthcare BPO Market by provider services:

  • Medical Billing
  • Medical Coding
  • Medical Transcription
  • Finance & Accounts

 

Healthcare BPO Market by payer services:

  • Integrated Front-end Services and Back-office Operations
  • Provider Management
  • Claims Management
  • Billing and Accounts Management
  • HR
  • Analytics and Fraud Management
  • Member Management

 

Healthcare BPO Market by pharmaceutical service:

  • Manufacturing
  • Research and Development
  • Non-clinical Services
    • Sales and Marketing
    • Supply Chain Management and Logistics
    • Other Non-clinical Functions
      • HR
      • Finance and Accounts
      • IT

 

Healthcare BPO Market by end-user:

  • Hospital
  • Dental Clinics
  • Public Service
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/#ulp-c654SbFYO64MsOhu

 

 

The major factor that drives the growth of healthcare BPO is increase in development of healthcare IT. Furthermore, new business models & processes and increase in use of digital technologies in healthcare are driving the growth of healthcare BPO market. Globally healthcare BPO market is expected to grow with a significant CAGR from 2016 to 2027. Rise in geriatric population is expected to be major factor, owing to the susceptibility to several health issues which includes respiratory disorders, cardiovascular diseases (CVD), eye care problems, orthopedic disorders, cancers etc. and rise in the prevalence rate of those diseases led to the increased amount of work for insurance companies. Hence, in order to handle that much of data about huge pool of patients and data of the payer companies need to invest in technology, skilled personnel and infrastructure which led to high operational cost which is anticipated to accelerate the healthcare payer BPO market.  Shift from the ICD-9 to ICD-10 coding system posed heavy workload for payers in order to up gradation of their systems, training of staff in turn increases the financial burden. The ICD-9 code system had 13,000 codes, while ICD-10 code system has nearly 68,000 codes. This variation augmented need for HR, accounting, medical coding, skilled personnel and technical operations, hence anticipated to propel the growth of the healthcare BPO markets.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/#ulp-14mlyhjMGhVjZqa3

 

 

Based on geography, the healthcare BPO market can be segmented into five major regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Currently, North America accounts a leading position in the healthcare BPO market followed by Europe. The major driving factors that have driven the growth of the healthcare BPO market in these regions are steadily increase in changes of regulatory scenario, pressure on healthcare institutions to reduce costs and rising trends for healthcare IT, big data and cloud computing. In the forecast period, Asia-Pacific region is expected to show remarkable growth in the healthcare BPO market as it is developing at a very rapid pace and has shown the emergence of many regional players. The factors that would fuel the growth of healthcare BPO market in Asia-Pacific are increasing awareness regarding various healthcare IT solutions, increase in the number of key players and rapid development in the healthcare infrastructure across the Asian countries.

 

Some of the top players operating in the healthcare BPO market are QuintilesIMS Inc., HCL Technologies Limited, Accenture, Eli Global, IBM Corporation, Genpact Limited, Parexel, Sutherland, Hewlett-Packard Inc., Truven Health Analytics,  United Health Group, Cognizant, Lonza Group Ltd, Accretive Health, Inc., Tata Consultancy Services Ltd, Xerox Corporation, Infosys Limited., and many others.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-healthcare-bpo-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Foley Catheters Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Foley catheter is also known as an indwelling catheter, which is inserted into bladder in order to drain the urine. It consists of a balloon which holds catheter inside the bladder at one of the end.  The balloon is filled with the sterile water for preventing the catheter from being removed from the bladder. The urine is drained into the collection tube through catheter. Foley catheters are used for long periods. These are used after the urological surgeries in order to help the patients to ease the urination in conditions like prostate hypertrophy nerve-related bladder dysfunction, narrowing of urethra and prostate cancer.

 

Foley Catheters market is anticipated to show significant growth during forecast period, due to increasing number of surgeries and rising demand of minimal invasive methods. In addition to this growing geriatric population and increasing demand for the sterile and disposable catheters, high reimbursement policies and technological advancements in the catheters are the factors which are fuelling the market growth. However, inadequate quality analysis and price sensitivity at domestic stages are hampering the market growth.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Global Foley Catheters market is segmented on the basis of type, material, end-user and geographical regions.

 

Based on the material, global foley catheters market is segmented as:

  • Latex
  • Silicone Elastomer Coated Latex
  • Silicone
  • Teflon Coated Latex
  • Hydrophilic Polymer Coated Latex

 

Based on the type, global foley catheters market is segmented as:

  • Indwelling catheter
  • Condom catheter
  • Intermittent catheters

 

Based on the end-user, global foley catheters market is segmented as:

  • Hospitals
  • Nursing Homes
  • Home care
  • Clinics
  • Ambulatory Surgical Centres

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-c654SbFYO64MsOhu

 

 

Globally, huge population is suffering with neurological, urological and cardiovascular, disorders who requires hospitalization in turn needs catheterization for the patients. As per World Health Organization (WHO), about 200 Mn people are suffering from the bladder control problems which require catheterization. As per the National Health Service (NHS) of UK, in 2013 imprecisely 3-6 Mn individuals are suffering from urinary incontinence in UK. Many market players are posing heavy investments in development of differencing products from the competitors’ products to enhance the competition, and players are focussing on the acquisitions, mergers and collaborations to enhance their market share.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/#ulp-14mlyhjMGhVjZqa3

 

 

Based on the geographical regions, foley catheters market is segmented as Latin America, North America, Asia-Pacific, Europe and Middle East and Africa. North America has the dominating market shares in Foley Catheters Market followed by Europe, especially Germany dominates the market growth while UK is the speedy growing market in Foley catheters market. The Asia-Pacific is anticipated to have rapid growth in foresee period due to high government support, a large pool of geriatric population suffering from various urinary problems which requires immediate catheterization, rise in income levels, and widespread of awareness.

 

Some of the market players in foley catheters market are Coloplast A/S. (Denmark), B. Braun Melsungen AG (Germany), Becton Dickinson & Co (U.S.), Boston Scientific Corporation (U.S.), Teleflex Incorporation (U.S.), Medtronic (U.S), CooK Medical. (U.S.), Hollister Incorporated (U.S.) and TE Connectivity Corporation (Switzerland).

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-foley-catheters-market/

more...
No comment yet.
Scooped by praveen12321
Scoop.it!

Global Congestive Heart Failure Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Congestive heart disappointment is an unending and dynamic condition that influences the drawing limit of heart muscles and furthermore alluded as "heart disappointment". Congestive heart disappointment can allude to the phase in which liquid develops around the heart and makes it pump wastefully. Ventricles draw blood to your body's organs and tissues, and the atria get blood from your body as it circles once more from whatever remains of your body. Congestive heart disappointment creates when ventricles unfit to draw adequate volume of blood to the body. In the long run, blood and different liquids can move down inside your lungs, liver, belly, and lower body. There are two sorts of congestive heart disappointment, they are systolic heart disappointment and diastolic heart disappointment.

 

Increment in predominance of cardiovascular infections crosswise over locales is one the central point anticipated that would drive the income development of congestive heart disappointment treatment universally. Way of life related elements are relied upon to add to developing malady rate of CVDs. Moreover developing number of hefty patients are required to support the congestive heart disappointment treatment advertise. ast track endorsements of medications in created nations will drive deals incomes for the organizations. Colossal treatment interest for congestive heart disappointment is relied upon to help the treatment advertise creating. Be that as it may, the accessibility of the nonexclusive medications and absence of end arrange pipeline medications and treatments for congestive heart disappointment treatment is going to block the market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-failure-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Congestive Heart Failure Treatment market is segmented on the basis of the drug class, route of administration, and distribution channel

 

Based on drug class, congestive heart failure treatment market is segmented as

  • Beta Blockers
  • ACE Inhibitors
  • Angiotensin Receptor Blockers
  • Diuretics
  • Inotropic Agents
  • Aldosterone Antagonist
  • Calcium Channel Blockers
  • Others

 

Based on route of administration, congestive heart failure treatment market is segmented as

  • Oral
  • Intravenous

 

Based on distribution channel, congestive heart failure treatment market is segmented as

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-failure-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Congestive heart failure treatment market is expected to show significant growth in demand over the forecast period owing to rising incidences of cardiovascular diseases. Congestive heart failure is one of the most common medical conditions that is responsible for the death of people globally. According to WHO, around 6.5 million of people are diagnosed with congestive heart failure every year and around 2% of global population are hospitalized due to congestive heart failure. In July, 2015, Novartis launched novel combination drug Entresto (LCZ-696) a novel branded CHF drug. The prescription of mineralocorticoid receptor antagonists (MRAs), such as spironolactone, due to their efficiency in heart failure treatment is expected to increase the Congestive heart failure (CHF) treatment markets during the forecast period.  Many generic manufacturers foray into the congestive heart failure treatment market due to patent expirations of CHF innovators drugs. The presence generics expected to hinder the market revenue and may hamper the uptake of new and expected novel drugs.

 

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-failure-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically congestive heart failure treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and European markets are significantly having high growth potential for congestive heart failure treatment due to the increase in incidences of heart failures in these regions. According to American Heart Association, Heart Disease and Stroke Statistics 2017, congestive heart failure occupies 8.5% of heart diseases in US. merging markets like Asia Pacific and Latin America are set to witness significant growth in this industry due to change in demographics, healthcare reforms, healthcare expenditure, and an increase in treatment for congestive heart failure conditions.

 

Some of the players in the global congestive heart failure (CHF) treatment market are AstraZeneca plc. (UK), Bristol-Myers Squibb Co. (U.S), GlaxoSmithKline plc (GSK) (UK), Merck & Co. Inc. (U.S), Mylan Inc. (U.S), Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), and Valeant Pharmaceuticals International Inc. (Canada)

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-congestive-heart-failure-treatment-market/

 

more...
No comment yet.